JP2020529477A5 - - Google Patents

Download PDF

Info

Publication number
JP2020529477A5
JP2020529477A5 JP2020529104A JP2020529104A JP2020529477A5 JP 2020529477 A5 JP2020529477 A5 JP 2020529477A5 JP 2020529104 A JP2020529104 A JP 2020529104A JP 2020529104 A JP2020529104 A JP 2020529104A JP 2020529477 A5 JP2020529477 A5 JP 2020529477A5
Authority
JP
Japan
Prior art keywords
composition
cdc
subject
cancer
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020529104A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020529477A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/044956 external-priority patent/WO2019028223A1/en
Publication of JP2020529477A publication Critical patent/JP2020529477A/ja
Publication of JP2020529477A5 publication Critical patent/JP2020529477A5/ja
Pending legal-status Critical Current

Links

JP2020529104A 2017-08-04 2018-08-02 がんの治療及び防止のためのカルディオスフィア由来細胞及びその細胞外小胞 Pending JP2020529477A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762541584P 2017-08-04 2017-08-04
US62/541,584 2017-08-04
PCT/US2018/044956 WO2019028223A1 (en) 2017-08-04 2018-08-02 CARDIOSPHERE-DERIVED CELLS AND THEIR EXTRACELLULAR VESICLES FOR THE TREATMENT AND PREVENTION OF CANCER

Publications (2)

Publication Number Publication Date
JP2020529477A JP2020529477A (ja) 2020-10-08
JP2020529477A5 true JP2020529477A5 (cg-RX-API-DMAC7.html) 2021-09-09

Family

ID=65234147

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020529104A Pending JP2020529477A (ja) 2017-08-04 2018-08-02 がんの治療及び防止のためのカルディオスフィア由来細胞及びその細胞外小胞

Country Status (4)

Country Link
US (2) US20210085724A1 (cg-RX-API-DMAC7.html)
EP (2) EP3661526B1 (cg-RX-API-DMAC7.html)
JP (1) JP2020529477A (cg-RX-API-DMAC7.html)
WO (1) WO2019028223A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
US11286463B2 (en) 2012-03-08 2022-03-29 Advanced ReGen Medical Technologies, LLC Reprogramming of aged adult stem cells
EP3563859B1 (en) 2012-08-13 2021-10-13 Cedars-Sinai Medical Center Cardiosphere-derived exosomes for tissue regeneration
US10772911B2 (en) 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
US20150174166A1 (en) 2013-12-20 2015-06-25 Advanced ReGen Medical Technologies, LLC Compositions for Cellular Restoration and Methods of Making and Using Same
CA2962444C (en) 2014-10-03 2023-09-05 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
EP3402543B1 (en) 2016-01-11 2021-09-08 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
CN109475645A (zh) 2016-04-29 2019-03-15 先进瑞金医疗技术有限公司 微rna组合物及其制备和使用方法
US11351200B2 (en) 2016-06-03 2022-06-07 Cedars-Sinai Medical Center CDC-derived exosomes for treatment of ventricular tachyarrythmias
WO2018057542A1 (en) 2016-09-20 2018-03-29 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
EP3612191B1 (en) 2017-04-19 2026-03-11 Cedars-Sinai Medical Center Methods and compositions for treating skeletal muscular dystrophy
US11660355B2 (en) 2017-12-20 2023-05-30 Cedars-Sinai Medical Center Engineered extracellular vesicles for enhanced tissue delivery
EP3740576A4 (en) 2018-01-18 2021-10-20 Advanced Regen Medical Technologies, LLC THERAPEUTIC COMPOSITIONS AND THEIR PREPARATION AND USE METHODS
EP3749344A4 (en) 2018-02-05 2022-01-26 Cedars-Sinai Medical Center METHODS OF THERAPEUTIC USE OF EXOSOMES AND Y-RNAS
KR102049505B1 (ko) * 2019-05-14 2019-11-29 이장호 젖산탈수소효소 b 및 페록시좀 증식인자-활성화 수용체 감마 활성화인자 1-알파가 함유된 면역관용화된 세포외소포의 제조방법 및 이를 이용한 항암용 조성물
EP4271396A4 (en) * 2021-01-04 2025-02-05 Biocardia, Inc. Cardiac stromal cell derived exosomes for ischemic heart repair
CA3237605A1 (en) * 2021-11-12 2023-05-19 Darryl Raymond DAVIS Compositions of human heart derived extracellular vesicles and uses thereof
CN117384822B (zh) * 2022-12-12 2024-03-29 北京大学口腔医学院 一种大鼠牙龈组织来源的凋亡囊泡的制备方法及其应用
US20250099391A1 (en) * 2023-09-08 2025-03-27 Wisconsin Alumni Research Foundation Compositions and Methods for Treating Cancer
WO2025083256A1 (en) * 2023-10-18 2025-04-24 Universite De Liege Modified exosomes or extracellular vesicles for cancer therapeutics

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20030376A1 (it) 2003-07-31 2005-02-01 Univ Roma Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
US20080267921A1 (en) 2004-11-08 2008-10-30 Johns Hopkins University Cardiac Stem Cells
CA2586276A1 (en) 2004-11-08 2006-05-18 The Johns Hopkins University Bioptome
PT2254586E (pt) * 2008-02-22 2015-05-18 Agency Science Tech & Res Partículas de células estaminais mesenquimais
US20120039857A1 (en) 2009-04-06 2012-02-16 Capricor, Inc. Systems and methods for cardiac tissue repair
US20120093885A1 (en) 2010-10-18 2012-04-19 Northwestern University Therapeutic vesicles
US20140004601A1 (en) 2010-12-20 2014-01-02 Agency For Science, Technology And Research Method of purifying exosomes
EP3563859B1 (en) * 2012-08-13 2021-10-13 Cedars-Sinai Medical Center Cardiosphere-derived exosomes for tissue regeneration
WO2015022545A2 (en) * 2013-08-14 2015-02-19 Reneuron Limited Stem cell microparticles and mirna
WO2015085096A1 (en) * 2013-12-04 2015-06-11 Board Of Regents, The University Of Texas System Analysis of genomic dna, rna, and proteins in exosomes for diagnosis and theranosis
US20160346334A1 (en) 2014-02-05 2016-12-01 Stc.Unm Exosomes as a therapeutic for cancer
US20170296591A1 (en) * 2014-10-03 2017-10-19 Cedars-Sinai Medical Center Cardiosphere-derived cells (cdcs) as therapeutic agents for pulmonary hypertension
CA2962444C (en) * 2014-10-03 2023-09-05 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
US20170304368A1 (en) * 2014-10-06 2017-10-26 Cedars-Sinai Medical Center Polarization of macrophages to a healing phenotype by cardiosphere-derived cells and by the exosomes secreted by such cells
WO2016152786A1 (ja) * 2015-03-20 2016-09-29 国立大学法人三重大学 細胞傷害性t細胞放出エキソソームによる癌間質間葉系細胞を標的とした腫瘍増殖及び転移抑制に係る治療薬
US11458097B2 (en) * 2016-03-30 2022-10-04 The University Of North Carolina At Chapel Hill Biological agent-exosome compositions and uses thereof

Similar Documents

Publication Publication Date Title
EP3985002B1 (en) Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
US11649223B2 (en) Amino compounds for treatment of immune and inflammatory disorders
US11649229B2 (en) Amide compounds for treatment of immune and inflammatory disorders
US11001600B2 (en) Disubstituted compounds for treatment of medical disorders
JP2015523355A5 (cg-RX-API-DMAC7.html)
WO2017035418A1 (en) Disubstituted compounds for treatment of immune and inflammatory disorders
WO2017035351A1 (en) Amino compounds for treatment of medical disorders
WO2017035411A1 (en) Ether compounds for treatment of immune and inflammatory disorders
WO2017035413A2 (en) Carbamate, ester, and ketone compounds for treatment of immune and inflammatory disorders
WO2017035415A1 (en) Alkyne compounds for treatment of immune and inflammatory disorders
WO2017035349A1 (en) Amide compounds for treatment of medical disorders
Liu et al. Strategies and opportunities of micro/nano delivery systems for targeted therapy of ulcerative colitis: Focus on underlying mechanisms and future perspectives
US20160361268A1 (en) Intralymphatic delivery of hyaluronan nanoparticle for cancer metastasis
JP2022502450A5 (cg-RX-API-DMAC7.html)
JP2018516936A5 (cg-RX-API-DMAC7.html)
Liu et al. Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology
Zhu et al. A controllable self-amplifying oxidative stress strategy for boosting noninvasive sonodynamic therapy and synergistic immunotherapy
Ng et al. Extracellular vesicles as delivery vehicles and therapeutic agents for glioblastoma treatment: a systematic review of in vitro and in vivo preclinical studies
Wang et al. Absorbable microspheres sustaining epirubicin and TLR7 agonist release for transarterial chemo-immuno-embolization in liver tumor
Wu et al. Tumor-homing cerium nanozyme platform enables coordinated drug release and STING activation for bladder cancer treatment
CN118304400A (zh) 包括细菌叶绿素衍生物的用于治疗癌症的联合疗法
JP2024522163A5 (cg-RX-API-DMAC7.html)
Hao Overview of Tumor Immunotherapy Based on Indoleamine 2, 3 Dioxygenase Inhibitors
JP2018516964A5 (cg-RX-API-DMAC7.html)
CN110575536A (zh) 降低纳豆激酶过敏性的组方及其应用